The ownership structure of Impel Pharmaceuticals (IMPL) stock is a mix of institutional, retail and individual investors. Approximately 67.84% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 32.16% is owned by Public Companies and Individual Investors.
The ownership structure of Impel Pharmaceuticals (IMPL) stock is a mix of institutional, retail and individual investors. Approximately 67.84% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 32.16% is owned by Public Companies and Individual Investors.
According to the latest TipRanks data, approximately 67.84% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 32.16% is held by retail investors.
What percentage of Impel Pharmaceuticals (IMPL) stock is held by institutional investors?
According to the latest TipRanks data, approximately 67.84% of Impel Pharmaceuticals (IMPL) stock is held by institutional investors.
What percentage of Impel Pharmaceuticals (IMPL) stock is held by retail investors?
According to the latest TipRanks data, approximately 32.16% of Impel Pharmaceuticals (IMPL) stock is held by retail investors.
Who owns the most shares of Impel Pharmaceuticals (IMPL)?
Currently, no data Available
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.